retatrutide phase 2 results obesity nejm 2023 🤔 Adults with type diabetes (T2D) and lose less weight on EVERY GLP-1 drug compared to those without diabetes, consistently ~5% less. Now that we have retatrutide's TRIUMPH-2 data today CagriSema vs Retatrutide: Amylin/GLP-1 Combination

GLP-1 drugs can only be prescribed to people after meeting stringent regulatory standards set by agencies like the FDA

Cardiovascular disease and risk management: standards of care in diabetes-2024

Because both agents sit at the center of intense marketing and online discussion, it is worth having a disciplined framework for reading any comparison including this one

A brief word on retatrutide Its a triple agonist hitting GLP-1, GIP, and glucagon receptors and the glucagon component is what sets it apart

Applications Retatrutide has a broad array of applications, primarily in the treatment of metabolic disorders

Biochem J